secwatch.observer — SEC 8-K summary
======================================

Issuer:     BillionToOne, Inc. (BLLN)
CIK:        0002070849
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0002070849-26-000013
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BillionToOne Q4 rev $96.1M (+113% YoY); net income $4.4M; raises FY26 guidance
------------------------------------------------------------------------------

- Q4 revenue $96.1M (+113% YoY); net income $4.4M ($0.11 diluted) vs loss of $11.5M.
- FY2025 revenue $305.1M (+100%); operating income $16.0M vs loss of $47.1M in 2024.
- Raised FY2026 revenue guidance to $430-$445M (41-46% growth) from prior $415-$430M.
- Gross margin improved to 71% in Q4 (from 57%) and 68% for FY (from 53%).
- Launched new prenatal (RBC/platelet NIPT) and oncology (Northstar PGx/CH) tests in Q1 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2070849/000207084926000013/0002070849-26-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2070849/000207084926000013/blln-20260304.htm
  HTML page:      https://secwatch.observer/filing/0002070849-26-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer